Neogenomics (NEO) Operating Margin (2010 - 2026)
Neogenomics (NEO) reported Operating Margin of 9.77% for Q1 2026, up 679.0% on a YoY basis from 1.25% in Q1 2025, and down 38.53% quarter-over-quarter from 7.05% in Q4 2025.
Neogenomics (NEO) Operating Margin (2010 - 2026) Analysis & Trends
Neogenomics has reported Operating Margin for 17 years, with the latest figure at 9.77% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 679.0% year-over-year to 9.77%; the trailing twelve-month figure through Mar 2026 stood at 14.25% (down 96.0% YoY), and the FY2025 full-year result was 15.93%, down 199.0% from the prior year.
- Operating Margin for Q1 2026 stood at 9.77%, down from 7.05% in the prior quarter.
- The five-year high for Operating Margin was 7.05% in Q4 2025, with the low at 44.4% in Q1 2022.
- Historically, Operating Margin has averaged 19.4% across 5 years, with a median of 16.56% in 2025.
- Annual changes were most pronounced in 2022 — Operating Margin plunged 3133 bps — and 2023, when it surged 1884 bps.
- Neogenomics' Operating Margin stood at 19.02% in 2022, then jumped by 37 bps to 11.94% in 2023, then increased by 10 bps to 10.7% in 2024, then soared by 34 bps to 7.05% in 2025, then sank by 39 bps to 9.77% in 2026.
- The last three Operating Margin figures came in at 9.77% (Q1 2026), 7.05% (Q4 2025), and 14.38% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.74% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 12.38% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -13.42% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 25.23% |
| 10 | Neogenomics | 1.41 Bn | 1.27 Bn | 80.86 Mn | -9.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.77% |
| Dec 31, 2025 | -7.05% |
| Sep 30, 2025 | -14.38% |
| Jun 30, 2025 | -26.27% |
| Mar 31, 2025 | -16.56% |
| Dec 31, 2024 | -10.70% |
| Sep 30, 2024 | -12.63% |
| Jun 30, 2024 | -13.34% |
| Mar 31, 2024 | -19.56% |
| Dec 31, 2023 | -11.94% |
| Sep 30, 2023 | -15.92% |
| Jun 30, 2023 | -20.35% |
| Mar 31, 2023 | -25.56% |
| Dec 31, 2022 | -19.02% |
| Sep 30, 2022 | -30.68% |
| Jun 30, 2022 | -31.74% |
| Mar 31, 2022 | -44.40% |
| Dec 31, 2021 | -33.06% |
| Sep 30, 2021 | -32.73% |
| Jun 30, 2021 | -18.38% |